Cargando…

Contrast-enhanced spectral mammography in neoadjuvant chemotherapy monitoring: a comparison with breast magnetic resonance imaging

BACKGROUND: Neoadjuvant-chemotherapy (NAC) is considered the standard treatment for locally advanced breast carcinomas. Accurate assessment of disease response is fundamental to increase the chances of successful breast-conserving surgery and to avoid local recurrence. The purpose of this study was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iotti, Valentina, Ravaioli, Sara, Vacondio, Rita, Coriani, Chiara, Caffarri, Sabrina, Sghedoni, Roberto, Nitrosi, Andrea, Ragazzi, Moira, Gasparini, Elisa, Masini, Cristina, Bisagni, Giancarlo, Falco, Giuseppe, Ferrari, Guglielmo, Braglia, Luca, Del Prato, Alberto, Malavolti, Ivana, Ginocchi, Vladimiro, Pattacini, Pierpaolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5594558/ https://www.ncbi.nlm.nih.gov/pubmed/28893303 http://dx.doi.org/10.1186/s13058-017-0899-1

Ejemplares similares

Accuracy and Reproducibility of Contrast-Enhanced Mammography in the Assessment of Response to Neoadjuvant Chemotherapy in Breast Cancer Patients with Calcifications in the Tumor Bed
por: Iotti, Valentina, et al.
Publicado: (2021)

Biomarkers Changes after Neoadjuvant Chemotherapy in Breast Cancer: A Seven-Year Single Institution Experience
por: Coiro, Saverio, et al.
Publicado: (2021)

Impact of low skeletal muscle mass and quality on clinical outcomes in patients with head and neck cancer undergoing (chemo)radiation
por: Bardoscia, Lilia, et al.
Publicado: (2022)

Accuracy of CT in a cohort of symptomatic patients with suspected COVID-19 pneumonia during the outbreak peak in Italy
por: Besutti, Giulia, et al.
Publicado: (2020)

Contrast-Enhanced Spectral Mammography: Comparison with Conventional Mammography and Histopathology in 152 Women
por: Luczyńska, Elzbieta, et al.
Publicado: (2014)

The value of computed tomography in assessing the risk of death in COVID-19 patients presenting to the emergency room
por: Besutti, Giulia, et al.
Publicado: (2021)

151P Personalized approach to mammography screening during the COVID pandemic: How to make up for lost time without losing effectiveness
por: Giovanardi, F., et al.
Publicado: (2022)

Comparison between Breast MRI and Contrast-Enhanced Spectral Mammography
por: Łuczyńska, Elżbieta, et al.
Publicado: (2015)

Contrast-enhanced spectral mammography with a compact synchrotron source
por: Heck, Lisa, et al.
Publicado: (2019)

Degree of Enhancement on Contrast Enhanced Spectral Mammography (CESM) and Lesion Type on Mammography (MG): Comparison Based on Histological Results
por: Łuczyńska, Elżbieta, et al.
Publicado: (2016)

Retrospective Comparison of Contrast-Enhanced Spectral Mammography with Digital Mammography in Assessing Tumor Size in 668 Cases of Breast Cancer
por: Lorek, Andrzej, et al.
Publicado: (2020)

Quantitative Analysis of Enhancement Intensity and Patterns on Contrast-enhanced Spectral Mammography
por: Liu, Ying, et al.
Publicado: (2020)

Contrast-Enhanced Spectral Mammography: Importance of the Assessment of Breast Tumor Size
por: Nicosia, Luca, et al.
Publicado: (2021)

Desmoplastic fibroma of the distal tibia: A case report of a minimally invasive histological diagnosis
por: Levrini, Gabriele, et al.
Publicado: (2016)

Contrast-enhanced mammography-guided biopsy: technical feasibility and first outcomes
por: Alcantara, R., et al.
Publicado: (2022)

Update on Anaplastic Thyroid Carcinoma: Morphological, Molecular, and Genetic Features of the Most Aggressive Thyroid Cancer
por: Ragazzi, Moira, et al.
Publicado: (2014)

The effectiveness of contrast-enhanced spectral mammography and magnetic resonance imaging in dense breasts
por: Rudnicki, Wojciech, et al.
Publicado: (2021)

Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
por: Liew, Amanda Ling Fung, et al.
Publicado: (2022)

Contrast-Enhanced Spectral Mammography in the Evaluation of Breast Microcalcifications: Controversies and Diagnostic Management
por: Nicosia, Luca, et al.
Publicado: (2023)

Imbalance of Mg Homeostasis as a Potential Biomarker in Colon Cancer
por: Schiroli, Davide, et al.
Publicado: (2021)

Initial outcome of contrast-enhanced spectral mammography in lesion characterisation in the mammographically dense breast
por: Hussain, Zeiad, et al.
Publicado: (2015)

Radiomic Analysis in Contrast-Enhanced Spectral Mammography for Predicting Breast Cancer Histological Outcome
por: La Forgia, Daniele, et al.
Publicado: (2020)

Contrast-Enhanced Spectral Mammography Assessment of Patients Treated with Neoadjuvant Chemotherapy for Breast Cancer
por: Steinhof-Radwańska, Katarzyna, et al.
Publicado: (2021)

Contrast-enhanced spectral mammography: are kinetic patterns useful for differential diagnoses of enhanced lesions?
por: Rong, Xiaocui, et al.
Publicado: (2023)

Evaluation of low-energy contrast-enhanced spectral mammography images by comparing them to full-field digital mammography using EUREF image quality criteria
por: Lalji, U. C., et al.
Publicado: (2015)

The association between clinical laboratory data and chest CT findings explains disease severity in a large Italian cohort of COVID-19 patients
por: Canovi, Simone, et al.
Publicado: (2021)

The Quality of Tumor Size Assessment by Contrast-Enhanced Spectral Mammography and the Benefit of Additional Breast MRI
por: Lobbes, Marc B.I., et al.
Publicado: (2015)

Diagnostic Value of Contrast-Enhanced Spectral Mammography in Comparison to Magnetic Resonance Imaging in Breast Lesions
por: Xing, Dong, et al.
Publicado: (2019)

Fully Automated Support System for Diagnosis of Breast Cancer in Contrast-Enhanced Spectral Mammography Images
por: Fanizzi, Annarita, et al.
Publicado: (2019)

Technique, protocols and adverse reactions for contrast-enhanced spectral mammography (CESM): a systematic review
por: Zanardo, Moreno, et al.
Publicado: (2019)

Contrast‐enhanced spectral mammography: A potential exclusion diagnosis modality in dense breast patients
por: Qin, Yun, et al.
Publicado: (2020)

Contrast-Enhanced Spectral Mammography Versus Ultrasonography: Diagnostic Performance in Symptomatic Patients with Dense Breasts
por: Lu, Zhongfei, et al.
Publicado: (2020)

A meta‐analysis of contrast‐enhanced spectral mammography versus MRI in the diagnosis of breast cancer
por: Xiang, Wanqing, et al.
Publicado: (2020)

Radiomic Feature Reduction Approach to Predict Breast Cancer by Contrast-Enhanced Spectral Mammography Images
por: Massafra, Raffaella, et al.
Publicado: (2021)

Contrast-enhanced spectral mammography (CESM)-guided breast biopsy as an alternative to MRI-guided biopsy
por: James, Jonathan
Publicado: (2022)

The quest of CMB spectral distortions to probe the scalar-induced gravitational wave background interpretation in PTA data
por: Tagliazucchi, Matteo, et al.
Publicado: (2023)

Multifocality and Multicentrality in Breast Cancer: Comparison of the Efficiency of Mammography, Contrast-Enhanced Spectral Mammography, and Magnetic Resonance Imaging in a Group of Patients with Primarily Operable Breast Cancer
por: Steinhof-Radwańska, Katarzyna, et al.
Publicado: (2021)

Expression of NOTCH1 in thyroid cancer is mostly restricted to papillary carcinoma
por: Piana, Simonetta, et al.
Publicado: (2019)

Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk
por: Giorgi Rossi, Paolo, et al.
Publicado: (2021)

Contrast-enhanced spectral mammography in the evaluation of breast suspicious calcifications: diagnostic accuracy and impact on surgical management
por: Houben, Ivo PL, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_f2llsl62kq24rhsdfmnkngsbs2